|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT01651468 |
|
Date of registration:
|
25/07/2012 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The Effect of the Nutraceutical "Hemofix" on the Coagulation System
|
|
Scientific title:
|
Phase 1 Study of the Nutraceutical "Hemofix" Safety and Effect on the Coagulation System |
|
Date of first enrolment:
|
September 2016 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
https://clinicaltrials.gov/show/NCT01651468 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
David Varon, Prof |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
HMO |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Healthy volunteers and volunteers with a mild bleeding disorder
Exclusion Criteria:
- people with thrombophilic and cardiovascular complications,
- people who are treated with anti-coagulants,
- women taking birth control pills
- people with a history hypercoagulability
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Von Willebrand Disease
|
|
Menorrhagia
|
|
Intervention(s)
|
|
Dietary Supplement: HEMOFIX
|
|
Primary Outcome(s)
|
|
bleeding and blood test results
[Time Frame: one year]
|
|
Secondary ID(s)
|
|
HEMOFIX- HMO-CTIL
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|